Delivery Order SPE2DR25D9168-SPE2DR26FCSE5
- Not listed
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for VABYSMO 6 mg/0.05 mL syringes, with a ceiling value of $8,821.68 and an ultimate completion date of March 24, 2026. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that provides firm fixed-price...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for Vabysmo 6 mg/0.05 mL syringes, with a ceiling value of $14,702.80, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, with a ceiling value of $22,054.20 for supply of VABYSMO 6 MG/0.05 ML syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge,...
- The Defense Logistics Agency issued a $5,881.12 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for VABYSMO 6 MG/0.05 ML syringes. PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a $65,066.40 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense medical facilities worldwide; DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), with a ceiling value of $4,361.95. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is placed against the company's single-award Indefinite Delivery Contract under the Defense Logistics Agency's PPV-G GEN V initiative, a $499.999 billion...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,821.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml syringes. The delivery order, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, was not issued under a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,488.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency issued a $1,526.64 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting defense medical supply needs. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is firm fixed price with place of performance in Park Ridge, IL 60068. Ultimate completion date is March 5, 2026. PPV-G GEN V is a...
- The Defense Logistics Agency issued a $1,465.18 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order carries a firm fixed price and an ultimate completion date of March 6, 2026. PPV-G GEN V is a Defense...
- SPE2DR25D9168Indefinite Delivery Contract
- SPE2DR25D9168-SPE2DR26FCSE5Delivery Order
The Defense Logistics Agency issued a $11,762.24 delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, for VABYSMO 6 mg/0.05 mL syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic pharmaceuticals, biologics, and medical consumables to Department of Defense military healthcare facilities worldwide. The parent IDC, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a $499.999 billion ceiling and extends through December 31, 2036. Place of performance is Park Ridge, Illinois. Ultimate completion date for this delivery order is April 1, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 3/10/26 |